Loratadine And Pseudoephedrine Sulfate Tablet, Film Coated, Extended Release
NDC Package 37808-724-69

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Loratadine And Pseudoephedrine Sulfate tablets is do not divide, crush, chew or dissolve the tabletadults and children 12 years and over1 tablet daily with a full glass of water; not more than 1 tablet in 24 hourschildren under 12 years of ageask a doctorconsumers with liver or kidney diseaseask a doctor. This formulation utilizes a tablet, film coated, extended release delivery system. Marketed by Heb, this product is identified by NDC 37808-724 and is authorized under FDA application ANDA076557.

Identification & Billing

NDC Package Code
37808-724-69
Package Description
10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
Product Code
11-Digit Billing Format
37808072469
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
10 EA
RxNorm Crosswalk
  • RxCUI: 1117562 - pseudoephedrine sulfate 240 MG / loratadine 10 MG 24HR Extended Release Oral Tablet
  • RxCUI: 1117562 - 24 HR loratadine 10 MG / pseudoephedrine sulfate 240 MG Extended Release Oral Tablet
  • RxCUI: 1117562 - loratadine 10 MG / pseudoephedrine sulfate 240 MG 24 HR Extended Release Oral Tablet

Clinical Specifications

Proprietary Name
Loratadine And Pseudoephedrine Sulfate
Non-Proprietary Name
Loratadine And Pseudoephedrine Sulfate
Substance Name
Loratadine; Pseudoephedrine Sulfate
Dosage Form
Tablet, Film Coated, Extended Release - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer; the tablet is formulated in such manner as to make the contained medicament available over an extended period of time following ingestion.
Administration Route
Oral - Administration to or by way of the mouth.
Usage Information
Do not divide, crush, chew or dissolve the tabletadults and children 12 years and over1 tablet daily with a full glass of water; not more than 1 tablet in 24 hourschildren under 12 years of ageask a doctorconsumers with liver or kidney diseaseask a doctor

Regulatory & Marketing

Labeler Name
Heb
Product Type
Human Otc Drug
FDA Application #
ANDA076557
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
02-01-2018
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 37808-724-69 identifies a specific commercial package of 10 tablet, film coated, extended release in 1 blister pack of Loratadine And Pseudoephedrine Sulfate, a human over the counter drug labeled by Heb. This product is billed for "EA" each discreet unit and contains an estimated amount of 10 billable units per package. This tablet, film coated, extended release is formulated for oral use and contains loratadine; pseudoephedrine sulfate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Heb on February 01, 2018. The current certification is valid through December 31, 2026.

How is this Heb product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 37808072469. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 10 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
37808-724-69
11-Digit CMS (5-4-2)
37808-0724-69

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.